Mn Services Vermogensbeheer B.V. Sells 13,200 Shares of MetLife, Inc. $MET

Key Points

• Mn Services Vermogensbeheer B.V. reduced its holdings in MetLife, Inc. by 5.7% during the 2nd quarter, selling 13,200 shares, leaving it with a total of 216,500 shares valued at $17.41 million.
• Analysts have varied opinions on MetLife's stock, with one Strong Buy, ten Buy, and one Hold rating, and a consensus price target of $95.55.
• MetLife recently announced a quarterly dividend of $0.5675 per share, yielding approximately 2.9%, with a payout ratio of 38.47%.

Mn Services Vermogensbeheer B.V. reduced its position in MetLife, Inc. (NYSE:MET - Free Report) by 5.7% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 216,500 shares of the financial services provider's stock after selling 13,200 shares during the period. Mn Services Vermogensbeheer B.V.'s holdings in MetLife were worth $17,411,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in MET. Ball & Co Wealth Management Inc. acquired a new position in shares of MetLife during the 4th quarter valued at $25,000. North Capital Inc. bought a new stake in shares of MetLife during the first quarter worth approximately $26,000. Motco raised its position in shares of MetLife by 105.5% during the first quarter. Motco now owns 413 shares of the financial services provider's stock worth $33,000 after purchasing an additional 212 shares during the period. WPG Advisers LLC bought a new position in shares of MetLife during the 1st quarter worth approximately $46,000. Finally, American National Bank & Trust increased its stake in shares of MetLife by 128.4% during the 1st quarter. American National Bank & Trust now owns 603 shares of the financial services provider's stock worth $48,000 after purchasing an additional 339 shares during the last quarter. 94.99% of the stock is owned by institutional investors and hedge funds.

MetLife Stock Up 0.1%

Shares of MET traded up $0.09 during mid-day trading on Friday, hitting $79.16. 8,848,968 shares of the company's stock were exchanged, compared to its average volume of 3,039,976. The firm has a fifty day moving average of $78.30 and a two-hundred day moving average of $78.12. MetLife, Inc. has a twelve month low of $65.21 and a twelve month high of $89.05. The stock has a market cap of $52.64 billion, a price-to-earnings ratio of 13.42, a P/E/G ratio of 0.71 and a beta of 0.87. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.57.

MetLife (NYSE:MET - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The financial services provider reported $2.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.32 by ($0.30). MetLife had a net margin of 5.83% and a return on equity of 19.88%. The business had revenue of $17.34 billion during the quarter, compared to the consensus estimate of $18.58 billion. During the same quarter in the previous year, the firm posted $2.28 EPS. The company's revenue for the quarter was down 2.7% compared to the same quarter last year. On average, sell-side analysts forecast that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 9th. Stockholders of record on Tuesday, August 5th were issued a dividend of $0.5675 per share. The ex-dividend date was Tuesday, August 5th. This represents a $2.27 annualized dividend and a dividend yield of 2.9%. MetLife's payout ratio is currently 38.47%.

Wall Street Analyst Weigh In

MET has been the subject of several research reports. Piper Sandler downgraded shares of MetLife from an "overweight" rating to a "neutral" rating and set a $84.00 price objective for the company. in a research note on Friday. JPMorgan Chase & Co. raised their price objective on MetLife from $86.00 to $95.00 and gave the company an "overweight" rating in a report on Tuesday, July 8th. Keefe, Bruyette & Woods dropped their target price on shares of MetLife from $94.00 to $92.00 and set an "outperform" rating on the stock in a report on Monday, August 11th. Jefferies Financial Group increased their target price on MetLife from $100.00 to $103.00 and gave the company a "buy" rating in a report on Monday, August 11th. Finally, Wells Fargo & Company restated an "overweight" rating and set a $97.00 price target (up previously from $94.00) on shares of MetLife in a report on Thursday, July 10th. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $94.64.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.